SYK

Stryker Corporation Common Stock (SYK)

Stock · NYSE · Health Care

$330.69as of 8/28/2026

AI Market Commentary

AI-generated

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

August 30, 2026

Seeking Alpha article focuses on Embecta, not Stryker. The recent Seeking Alpha piece from The Bottom Fishing Club highlights Embecta as a turnaround opportunity within defensive medical products. The article discusses Embecta's business and outlook, not Stryker's. Stryker, a larger medical device company, is only tangentially connected through the broader medical products space, and the article does not address SYK's financials, products, or recent performance. No direct catalyst for SYK appears in the news provided.

Active signals

Support level
$324.31
Industry
Medical/Dental Instruments

About SYK

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care di…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
56,000

Fundamentals

1-day range
$331$343.9
Market cap
$129.43B
P/E (trailing)
35.17
P/E (forward)
20.28
EPS (trailing)
$9.65
Dividend yield
1.02%
Beta
0.77
Avg. volume
2.58M
Ex-dividend date
September 30, 2026
Dividend pay date
October 30, 2026
52-week range
$281$396.86
Next earnings: October 29, 2026 · EPS estimate $3.60After Closeconfirmed

How Stryker Corporation Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$25.12BNet Income$3.25B (13%)Cost of Revenue$9.05B (36%)SG&A$8.65B (34%)R&D$1.62B (6%)Other$1.28B (5%)Tax$1.27B (5%)SYK

Source: 10-K filed Feb 11, 2026 · via SEC EDGAR / Finnhub

Forecasts

25 analyst ratings

Buy 82%
Hold 18%
Sell 0%
1-year price forecast
High
$465
+40.6%
Median
$382
+15.5%
Low
$315
-4.7%

Stryker Corporation Common Stock Competitors

Chosen by industry and closest market cap.

  • SYK
    Stryker Corporation Common Stock
    $330.67
    ▲ 2.65%
    Market cap $129.43BP/E 35.17
    $281$396.86
  • BSX
    Boston Scientific Corporation Common Stock
    $46.83
    ▲ 0.34%
    Market cap $71.45BP/E 20.40
    $42.2$109.5
  • MDLN
    Medline Inc. Class A Common Stock
    $35.29
    ▲ 1.85%
    Market cap $45.34BP/E 67.50
    $32.49$50.88
  • RMD
    ResMed Inc. Common Stock
    $240.24
    ▲ 1.90%
    Market cap $32.38BP/E 21.47
    $180.27$284.87
  • DXCM
    DexCom Inc. Common Stock
    $90.8
    ▲ 1.69%
    Market cap $31.33BP/E 34.53
    $54.11$92.59
  • BAX
    Baxter International Inc. Common Stock
    $26.12
    ▲ 0.77%
    Market cap $13.96BP/E
    $15.73$30
  • GMED
    Globus Medical Inc. Class A Common Stock
    $83.06
    ▲ 0.63%
    Market cap $11.01BP/E 21.55
    $54.15$101.4

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
0
Disposed
179.3K

Institutional Ownership

March 31, 2026

Total shares held
272.96M
Total value held
$84.00B
Institutional holders
2272
Top holders this quarter
  • Unknown27.60M
  • Unknown22.38M
  • Unknown15.94M
  • Unknown15.35M
  • Unknown10.04M
  • Unknown8.12M
  • Unknown7.75M
  • Unknown6.30M
  • Unknown6.05M
  • Unknown5.61M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.